About Us

The Ellogon.AI team shares a single passion: contribute to improving the outcome of cancer. To realize this we have put together a team with all the right ingredients. We are happy to introduce you to our team!



2019 May

Incorporation as spin-off University of Amsterdam

2020 July

Focus on immunotherapy and € 1 mio. grant win with Netherlands Cancer Institute

2021 October

Obtained another € 1 mio in non-dilutive funding

2021 December

Grown team from 2 to 5 FTE

2022 March

Grown team from 5 to 9 FTE

2022 April

Obtained CE certification under IVDD